A PYMNTS Company

Senator Kohl sends cautionary letter to FTC re: Express Scripts-Medco merger

By  |  February 2, 2012

Senator Herb Kohl, chairman of the Senate Judiciary subcommittee on antitrust and consumer protection, sent a cautionary letter to the FTC on the proposed Express Scripts and Medco merger.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    As quoted by MarketWatch, Senator Kohl wrote, “Express Scripts’ proposed merger with Medco will unquestionably create a giant PBM [pharmacy benefits manager] that is substantially larger than any competitor, and will result in the combined entity having a dominant market share in mail order and specialty pharmacies. [. . .] It will reduce choices for PBM services to health plan sponsors, especially large employers. And it has the potential to have profound effects on the ability of both community and chain drug stores to compete.”

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Senator Kohl’s letter also expressed doubts that smaller PBMs will be able to sustain competition for large plan sponsors, and that substantial cost savings will result from the merger.

    Source: MarketWatch

     

    Related content: New Horizontal Merger Guidelines Indicate Greater Scrutiny of High Tech and Pharmaceutical Transactions (Janet McDavid & Eric Stock, Hogan Lovells)